Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients.
نویسندگان
چکیده
BACKGROUND Liver steatosis can progress to fibrosis, cirrhosis, and eventually to end-stage liver disease and hepatocellular carcinoma. We thus determined the prevalence of liver steatosis and fibrosis in patients undergoing bariatric surgery using liver biopsy. We also determined the suitability of ultrasound for diagnosis of liver steatosis with and without simultaneously considering patient characteristics. METHODS We reviewed preoperative liver ultrasound and intraoperative liver biopsy results in 451 bariatric surgery patients along with their clinical characteristics between 2005 and 2009. RESULTS Among 435 patients with conclusive biopsy results, estimated prevalence of liver steatosis was 71.5% (95% confidence interval 67%, 76%) and that of fibrosis was 27% (23%, 31%). Sensitivity of ultrasound for liver steatosis was 86% (82%, 90%); its specificity was 68% (59%, 76%). Positive predictive value of ultrasound for liver steatosis was 87% (82%, 91%), and its negative predictive value was 67% (58%, 75%). Overall diagnostic accuracy was 81% (77% 85%). Sensitivity was improved in patients with higher nonalcoholic fatty liver disease activity scores (NAS) [odds ratio (OR) 1.4 (1.1, 1.9) for a one unit increase in NAS] and prolonged duration of obesity [OR 1.3 (1.1, 1.6) for a 5-year increase in duration] but was worsen by higher body mass index. CONCLUSIONS About three quarters of bariatric surgery patients have liver steatosis, and about a quarter have fibrosis. One third of patients with liver steatosis develop fibrosis without significant clinical manifestations. Ultrasound was only moderately diagnostic for liver steatosis but was sufficient for clinical use in patients with a NAS score ≥2 and when the duration of obesity was >30 years.
منابع مشابه
Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C
Background: Hepatic steatosis is commonly observed in patients with chronic hepatitis C (CHC). Many studies indicate a relationship between steatosis and fibrosis progression. The aim of this study was to analyze the prevalence of hepatic steatosis and related factors in Iranian CHC patients. Methods: One hundred and fifteen consecutive patients with CHC were enrolled which were treat...
متن کاملUsefulness of an index score as a predictor of hepatic fibrosis in obese patients undergoing bariatric surgery.
OBJECTIVE To evaluate the usefulness of a non-invasive clinical score to predict liver fibrosis in the steatosis associated with morbid obesity. PATIENTS AND METHODS We included 88 patients, who underwent bariatric surgery in the Sanitary Area of León, Spain, and who showed a liver biopsy with steatosis greater than 5%. This is a retrospective study in which the rate of fibrosis is calculated...
متن کاملBackground: Hepatic steatosis is commonly observed in patients with chronic hepatitis C (CHC). Many studies indicate a relationship between steatosis and fibrosis progression. The aim of this study was to analyze the prevalence of hepatic steatosis and related factors in Iranian CHC patients. Methods: One hundred and fifteen consecutive patients with CHC were enrolled which were treat...
متن کاملValidation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.
BACKGROUND Liver biopsy is considered as the gold standard for assessing nonalcoholic fatty liver disease (NAFLD) histologic lesions in patients with morbid obesity. The aim of this study was to determine the diagnostic utility of noninvasive markers of fibrosis (FibroTest), steatosis (SteatoTest), and steatohepatitis (NashTest, ActiTest) in these patients. MATERIALS AND METHODS Two hundred a...
متن کاملNew clinical score to diagnose nonalcoholic steatohepatitis in obese patients
BACKGROUND Nonalcoholic fatty liver disease (NAFLD) is the most frequent disease associated with abnormal liver tests that is characterized by a wide spectrum of liver damage, ranging from simple macro vesicular steatosis to steatohepatitis (NASH), cirrhosis or liver carcinoma. Liver biopsy is the most precise test to differentiate NASH from other stages of NAFLD, but it is an invasive and expe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Obesity surgery
دوره 22 2 شماره
صفحات -
تاریخ انتشار 2012